Bifeprunox:: A new atypical antipsychotic with in vivo, agonistic activity at the 5-HT1A receptor

被引：0
|
作者：
Hertel, P
Husum, H
Marquis, K
Herremans, AHJ
Hesselink, MB
机构：
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Bifeprunox:: a novel atypical antipsychotic with in vivo 5-HT1A receptor agonistic activity
    Herremans, AHJ
    Hertel, P
    Husum, H
    Marquis, K
    Van der Heyden, J
    McCreary, AC
    Hesselink, MB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S488 - S488
  • [2] Bifeprunox:: A novel atypical antipsychotic sharing dopamine D2 receptor partial agonism and serotonin 5-HT1A receptor agonism
    Marquis, KL
    Hertel, P
    Reindeers, JH
    van der Neut, M
    Ronken, E
    Hesselink, MB
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 305 - 305
  • [3] New Serotonin 5-HT1A Receptor Agonists Endowed with Antinociceptive Activity in Vivo
    Valhondo, Margarita
    Marco, Isabel
    Martin-Fontecha, Mar
    Vazquez-Villa, Henar
    Ramos, Jose A.
    Berkels, Reinhard
    Lauterbach, Thomas
    Benhamu, Bellinda
    Lopez-Rodriguez, Maria L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (20) : 7851 - 7861
  • [4] Synthesis and 5-HT1A, 5-HT2A receptor activity of new β-tetralonohydantoins
    Byrtus, H
    Pawlowski, M
    Czopek, A
    Bojarski, AJ
    Duszyanska, B
    Nowak, G
    Klodzinska, A
    Tatarczynska, E
    Wesolowska, A
    Chojnacka-Wójcik, E
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (08) : 820 - 829
  • [5] Perospirone, a novel atypical antipsychotic with potent binding affinities for 5-HT1A and 5-HT2A receptors, increases prefrontal dopamine levels via 5-HT1A receptor activation
    Kuroki, T
    Kajihata, T
    Nakahara, T
    Yamada, H
    Hashimoto, K
    Ichikawa, J
    Kanba, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S266 - S266
  • [6] Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism
    McCreary, Andrew C.
    Jones, Caitlin A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (05) : 516 - 521
  • [7] Serotonin, 5-HT2A receptor occupancy in vivo and response to the new atypical antipsychotic quetiapine
    Jones, HM
    Travis, MJ
    Mulligan, R
    Bressan, R
    Visvikis, D
    Gacinovic, S
    Ell, PJ
    Kerwin, RW
    Pilowsky, LS
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 245 - 245
  • [8] EFFECTS OF NOVEL 5-HT1A RECEPTOR ANTAGONISTS ON MEASURES OF POSTSYNAPTIC 5-HT1A RECEPTOR ACTIVATION IN-VIVO
    THIELEN, RJ
    FRAZER, A
    LIFE SCIENCES, 1995, 56 (07) : PL163 - PL168
  • [9] Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity:: Role in atypical antipsychotic action
    Díaz-Mataix, L
    Scorza, MC
    Bortolozzi, A
    Toth, M
    Celada, P
    Artigas, F
    JOURNAL OF NEUROSCIENCE, 2005, 25 (47): : 10831 - 10843
  • [10] Atypical antipsychotic profile of BTS 79 018 may be mediated by central 5-HT1A agonist activity
    Needham, PL
    Gross, G
    Wicke, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U90 - U90
12345